NVNO

NASDAQ open

enVVeno Medical

9.06 USD
-0.27-2.84%
盘后 11.62 0.00%
2026-09-16
市值
$6.18M
市盈率
EPS
-24.90
股息率
52 周区间
7.80 – 35.70
成交量
37.13K
Beta
1.07
目标价
52W 低 7.8052W 高 35.70
价格走势

公司简介

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company’s lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcathe...